Core Insights - IBA has signed a contract with China Gold Irradiation (CGI) to install a Rhodotron in Jiaxing, marking a significant step in the advancement of China's irradiation processing industry towards high-quality development [1][5]. Company Overview - IBA is a leader in particle accelerator technology, specializing in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry, with approximately 2,100 employees globally [7]. - China Gold Irradiation focuses on irradiation processing and technology services, managing gamma and E-beam centers across multiple cities in China [8]. Technological Advancements - The Jianxing center will be the first CGI facility to implement X-ray technology, enhancing irradiation capacity for medical devices and related industries, including biological and traditional Chinese medicine products [2]. - The IBA Rhodotron TT1000 system can treat over 60,000 pallets annually and is equivalent to a five million curies gamma irradiation center using cobalt, with a price range of EUR 12 million to 15 million [4]. Market Trends - As cobalt availability becomes limited, X-ray technology is emerging as a sustainable alternative for the sterilization industry, with CGI investing in this technology to meet diverse industrial needs [3][5]. - The agreement signifies a growing momentum for X-ray technology in China, positioning CGI as a pioneer in adopting X-ray solutions and facilitating the transition from gamma to X-ray technologies [5].